We serve Chemical Name:Methyl 6-bromonicotinate CAS:26218-78-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methyl 6-bromonicotinate
CAS.NO:26218-78-0
Synonyms:methyl 6-bromopyridine-3-carboxylate;Methyl 6-bromonicotinate;6-Bromopyridine-3-carboxylic Acid Methyl Ester;MFCD04972371;3-Pyridinecarboxylic acid, 6-bromo-, methyl ester;6-Bromonicotinic acid methyl ester
Molecular Formula:C7H6BrNO2
Molecular Weight:216.032
HS Code:2933399090
Physical and Chemical Properties:
Melting point:119-121ºC
Boiling point:278.1±20.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.554
PSA:39.19000
Exact Mass:214.958176
LogP:1.67
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like methyl 6-bromopyridine-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Bromonicotinic acid methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 6-bromopyridine-3-carboxylate Use and application,Methyl 6-bromonicotinate technical grade,usp/ep/jp grade.
Related News: Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. Methyl 6-bromonicotinate manufacturer Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings. Methyl 6-bromonicotinate supplier The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this. Methyl 6-bromonicotinate vendor Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. Methyl 6-bromonicotinate factory Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.
